Culturally-Adapted Smoking Cessation Mobile App for Hispanic Individuals Who Smoke
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Smoking Cessation
- Sponsor
- University of Houston
- Enrollment
- 56
- Primary Endpoint
- 7-Day Point Prevalence Smoking Abstinence
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
The specific aims of the project are to develop and test a mobile application for smoking cessation for Hispanic individuals who smoke called Impacto.
Detailed Description
A total of 56 Hispanic individuals who smoke will be recruited for this project. Six (6) participants will complete usability/functionality testing of Impacto 2.0 in the English language for both iOS and Android. Following usability/functionality testing, a field test with 50 adult Hispanic individuals who smoke (50% English-speaking and 50% Spanish-speaking) will be recruited nationally and will receive Impacto 2.0 (50% Android and iOS platforms).
Investigators
Michael J. Zvolensky, Ph.D.
Hugh Roy and Lillie Cranz Cullen Distinguished University Professor
University of Houston
Eligibility Criteria
Inclusion Criteria
- •being Hispanic, 2) at least 18 years of age, 2) currently smoking (i.e., at least 5 cigarettes/day) biochemically verified by a CO \> 7, 3), meeting criteria for high AS (cut-off score of 5 on the Short Scale Anxiety Sensitivity Index), 4) motivation to quit \> 5 on a 10 pt. scale, 5) able to provide informed consent, 6) has daily access to their own iPhone or Android smartphone, and 7) is a fluent English or Spanish speaker.
Exclusion Criteria
- •current participation in substance abuse treatment, 2) in psychotherapy for anxiety or depression, 3) concurrent use of medication for anxiety or depression, 4) active suicidality (ideation, intent, and/or plan), or 5) current psychosis.
Outcomes
Primary Outcomes
7-Day Point Prevalence Smoking Abstinence
Time Frame: End of treatment (Week 8)
7-day point prevalence smoking status (verification via carbon monoxide).
Secondary Outcomes
- Anxiety Sensitivity(Baseline, week 4, and end of treatment (Week 8))